Connect with us

National

Still Smarting Over Poll Results, Nitish Kumar Snubs Chirag Paswan – dot newz

Published

on


Nitish Kumar’s JDU, which ended up with fewer seats in elections, had blamed it on Chirag Paswan

Patna:

Bihar Chief Minister Nitish Kumar made it clear that he is not ready to bury the hatchet with Lok Janshakti Shakti Party’s Chirag Paswan over his role in the state elections, which pushed the Janata Dal United to the second place in the state’s ruling alliance.

Mr Kumar skipped the programme for the first death anniversary of Mr Paswan’s father Ram Vilas Paswan – attended by almost all important political leaders in the state.

No reason was cited for his absence. His office just released a one-line press release that said he paid his respects to the departed leader.

Leaders of Mr Kumar’s alliance partner BJP turned out in strength for the ceremony organised in Patna.

Senior BJP leader Sushil Modi flew in from Bengaluru to attend the ceremony, leaving his ailing son in hospital. He also tweeted on the occasion.

“Ram Vilas Paswan was not only a leader of the Dalits, but a serious person who took care of all sections of the society, so people rose above party sentiment and came to pay tribute to him,” reads a rough translation of hi Hindi tweet.

Governor Phalgu Chauhan was the first to turn up at the venue. Bihar Assembly Speaker Vijay kumar Sinha, Chairman of the Bihar Legislative Council Avadesh Narayan Singh, Deputy Chief Minister Renu Devi, Union Minister Nityanand Rai and several BJP ministers in Mr Kumar’s cabinet were also present. Former Chief Minister Jitan Ram Manjhi was also among those who came early.

Since the election, Mr Kumar has made his displeasure with Chirag Paswan clear. Despite repeated requests, he had refused to grant an audience to the young leader, whose party split in June. The breakaway faction is led by his uncle Pashupati Paras, the younger brother of Ram Vilas Paswan.

Mr Kumar’s party, which ended up with far fewer seats in the assembly elections, has blamed it on Chirag Paswan, who rebelled against the Chief Ministers leadership. Mr Paswan’s LJP had contested against the JDU in most seats, which Mr Kumar and his party leaders said, led to a division of votes.

Chirag Paswan, who was upset when Mr Kumar did not visit his ailing father, today said he had made every effort to ensure the Chief Minister’s presence at the ceremony.

“I have asked for time but it is not easy to meet the Chief Minister. Especially when it comes to me, he does not give an appointment. I hope he gives me an audience at least before the event,” Mr Paswan had earlier said.

“I invited him even through the media. Our friends met him yesterday and invited him as well. But no one accepted,” Mr Paswan told reporters today. “I think there are some moments that are above politics. He had rivalry with our leader (Ram Vilas Paswan). I do hope Chief Minister Nitish Kumar comes for a few minutes and pays his respect to our leader,” he added.

Leader of Opposition Tejashwi Yadav, who attended the event with several senior leaders of Lalu Yadav’s Rashtriya Janata Dal, pulled no punches. “He is elder to us… He has been a Chief Minister for 15 years. He is like our uncle. But there is a courtesy which should have been observed. Even the Prime Minister wrote much. But Nitish Kumar finished it off in a single line,” he said.

But he also added that this was the Chief Minister’s “personal decision” and “no one can force him”. “We don’t want any politics over this,” he said.



Source link

National

Coronavirus Live News Update: India Creates World Record In Vaccinations With 2.5 Crore Doses In A Day – dot newz

Published

on

By


The government had set out with a target of 2.5 crore vaccinations and crossed the mark by 10,390

India crossed 2.5 crore Covid vaccinations in a day for the first time on Friday as the government raced to deliver a record on Prime Minister Narendra Modi’s birthday. Union Health Minister Mansukh Mandaviya tweeted to confirm the “historic” figure.

The government had set out with a target of 2.5 crore vaccinations and crossed the mark by 10,390.

With 34,403 more people testing positive for COVID-19, India’s overall infection tally has increased to 3,33,81,728, while the count of active cases has dipped to 3,39,056, according to Union health ministry data updated on Friday.

The death count due to the disease has climbed to 4,44,248 with 320 more fatalities being recorded, it said.

The number of active cases now comprises 1.03 per cent of the total infections, while the national COVID-19 recovery rate has been recorded at 97.64 per cent, according to the data updated by the ministry.

It said that active COVID-19 cases in the country decreased by 3,867 cases in a span of 24 hours.

Here are the updates on coronavirus (COVID-19) cases:

Over 7 lakh people vaccinated in Assam on PM’s birthday

A total of 7,09,524 people received the COVID-19 vaccine in Assam on Friday as the state government undertook a mega inoculation drive on the occasion of Prime Minister Narendra Modi’s birthday, a bulletin said.

Over 2.16 crore people have been immunised, and 44.02 lakh of them got both doses of the vaccines, it said.

The special drive was conducted in 4,575 COVID Vaccination Centres (CVCs), of which 4,557 were government sites and 18 private ones.



Source link

Continue Reading

National

WHO Emergency Approval For Covaxin Delayed Till October 5 – dot newz

Published

on

By


The assessment of the SAGE working group on the available pieces of evidence will determine EUA.

New Delhi:

World Health Organisation’s (WHO) approval for the emergency use authorisation (EUA) to COVID-19 vaccine Covaxin, developed by the Hyderabad-based Bharat Biotech, is likely to be delayed till October 5.

As per WHO, the Strategic Advisory Group of Experts on Immunization (SAGE) will be meeting on October 5 to granting EUA to Covaxin.

Hanna Nohynek, SAGE member will be introducing session objective setting, an update on regulatory decisions and an overview of Working Group deliverables.

The session will recommend EUA based on the clinical data on Covaxin from phase 1, 2, 3 trial and post-marketing studies on safety, immunogenicity, efficacy and effectiveness.

It will update on global, regional and country-level plans for vaccine safety monitoring.

The assessment of the SAGE working group on the available pieces of evidence will determine EUA.

Meanwhile, Bharat Biotech on Friday said it has submitted all the data to the World Health Organisation (WHO) for Emergency Use Listing (EUL) of its COVID-19 vaccine Covaxin and is awaiting feedback from the UN Public Health Agency.

In a series of tweets, Bharat Biotech said that Covaxin clinical trial was fully compiled and available in June 2021.

“#COVAXIN clinical trial data was fully compiled and available in June 2021. All Data was submitted for Emergency Use Listing (EUL) Application to World Health Organization in early July. We have responded to any clarifications sought by #WHO and are awaiting further feedback,” Bharat Biotech tweeted.

As a responsible manufacturer with past approvals for its other vaccines, the company said it would not find it appropriate to speculate or comment on the approval process and its timelines, it further said.

“We are continuing to work diligently on obtaining WHO EUL at the earliest,” it added.

Bharat Biotech has submitted its Phase 3 clinical trials data that demonstrated 77.8 per cent efficacy to the Subject Expert Committee (SEC) of the Central Drugs Standard Control Organisation (CDSCO).

Covaxin was developed by Hyderabad-based Bharat Biotech in association with the Indian Council of Medical Research and the National Institute of Virology. Covaxin, which has been developed in collaboration with the Indian Council of Medical Research (ICMR), contains a whole virion inactivated SARS-CoV-2 vaccine, which is produced in Vero cells.

The vaccine is stable at 2 degrees Celsius to 8 degrees Celsius (refrigerated) and is shipped in a ready-to-use liquid formulation that permits distribution using existing vaccine supply chain channels.

The WHO has so far approved Covid vaccines developed by Pfizer-BioNTech, US pharma majors Johnson & Johnson, Moderna, China’s Sinopharm and Oxford-AstraZeneca for emergency use.

(Except for the headline, this story has not been edited by NDTV staff and is published from a syndicated feed.)





Source link

Continue Reading

National

PM Praises Frontline, Health Workers As India Administers Over 2 Crore Doses – dot newz

Published

on

By


PM Praises Frontline, Health Workers As India Administers Record Doses

New Delhi:

As India set a new record on Friday by administering over 2 crores COVID-19 vaccine doses, Prime Minister Narendra Modi dedicated the success of the vaccination drive to the country’s doctors, innovators, administrators, nurses, healthcare and all front-line workers.

“Every Indian would be proud of today’s record vaccination numbers. I acknowledge our doctors, innovators, administrators, nurses, healthcare and all front-line workers who have toiled to make the vaccination drive a success. Let us keep boosting vaccination to defeat COVID-19,” PM Modi tweeted.

Bharatiya Janata Party (BJP) and several state governments have aimed to make Prime Minister Narendra Modi’s birthday historic by setting a record number of Covid vaccinations Friday.

Taking to Twitter, Union Health Minister Mansukh Mandaviya said that the historic feat is a gift to PM Modi on behalf of the health workers and the countrymen.

“#VaccineSeva A gift to Prime minister Narendra Modi on behalf of the health workers and the countrymen. Today, on his birthday, India has crossed the historical figure of administering 2 crore vaccines in a day, setting a new record. Well done India!” Mandaviya tweeted.

India has administered more than one crore COVID-19 vaccines in a day on earlier occasions.The vaccination drive in the country commenced on January 16 with the inoculation of healthcare and frontline workers. At present, India is administering COVID-19 vaccines– Covishield of Serum Institute of India (SII), Bharat Biotech”s Covaxin and Sputnik V.

To ramp up the drive, on April 1, the government had opened Covid-19 vaccination for everyone above the age of 45 years. A month later from May 1, as a part of the third phase of the vaccination drive, India began administering the vaccine in the 18 to 44 years age group.

Since then, the country’s vaccination drive is scaling new heights. On August 9, India’s COVID-19 vaccination coverage crossed the landmark of 50 crores.

(Except for the headline, this story has not been edited by NDTV staff and is published from a syndicated feed.)





Source link

Continue Reading

Trending

Copyright © 2017 Dot Newz | Developed by MCVP Group 8